Showing results (11-20 of 34) with videos related to
Sort By:
Pageof 4
Journal of Virology|September 13, 2019
Type I and Type III Interferons Differ in Their Adjuvant Activities for Influenza VaccinesLiang Ye, Annette Ohnemus, Li Ching Ong, et al.Frontiers in Immunology|October 18, 2021
Interferon-λ Improves the Efficacy of Intranasally or Rectally Administered Influenza Subunit Vaccines by a Thymic Stromal Lymphopoietin-Dependent MechanismLiang Ye, Daniel Schnepf, Annette Ohnemus, et al.Nucleic Acids Research|May 1, 2015
Structural and functional analysis reveals that human OASL binds dsRNA to enhance RIG-I signalingMikkel Søes Ibsen, Hans Henrik Gad, Line Lykke Andersen, et al.The Journal of Biological Chemistry|June 27, 2020
Inhibition of SARS-CoV-2 by type I and type III interferonsUlrike Felgenhauer, Andreas Schoen, Hans Henrik Gad, et al.Science (New York, N.Y.)|June 13, 2020
Type I and III interferons disrupt lung epithelial repair during recovery from viral infectionJack Major, Stefania Crotta, Miriam Llorian, et al.EMBO Molecular Medicine|August 14, 2016
IFNλ is a potent anti-influenza therapeutic without the inflammatory side effects of IFNα treatmentSophia Davidson, Teresa M McCabe, Stefania Crotta, et al.Elife|April 14, 2018
IFN-λ prevents influenza virus spread from the upper airways to the lungs and limits virus transmissionJonas Klinkhammer, Daniel Schnepf, Liang Ye, et al.Journal of Interferon & Cytokine Research : the Official Journal of the International Society for Interferon and Cytokine Research|October 19, 2018
Species Specificity of Type III Interferon Activity and Development of a Sensitive Luciferase-Based Bioassay for Quantitation of Mouse Interferon-λSophie Jacobs, Fanny Wavreil, Bert Schepens, et al.Medical Microbiology and Immunology|June 8, 2019
Defective interferon priming and impaired antiviral responses in a patient with an IRF7 variant and severe influenzaMichelle M Thomsen, Sofie E Jørgensen, Hans Henrik Gad, et al.The Journal of Biological Chemistry|February 25, 2010
Selection of a novel and highly specific tumor necrosis factor alpha (TNFalpha) antagonist: insight from the crystal structure of the antagonist-TNFalpha complexPovilas Byla, Mikkel H Andersen, Thor L Holtet, et al.Pageof 4